trial

Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia

NCTId NCT02916121
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 88 (estimated)
Sponsored by Taipei Medical University Shuang Ho Hospital
Primary completion 2018-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
88 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2016-10
Primary completion
2018-08
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
folic acid 5 mg/cap

Sponsors

Taipei Medical University Shuang Ho HospitalLead Sponsor

Investigators

1
Chun-Hsin Chen, MDPrincipal Investigator

Sites

1 total
Taipei, Taiwan

Facts & assertions

4 sourced
Enrollment
88
Phase
NA
Primary Completion Date
2018-08
Status
UNKNOWN
relationships
The graph out of here
drug
folic acid 5 mg/cap
drug
lead_sponsor
Taipei Medical University Shuang Ho Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Chun-Hsin Chen, MD
person